Found: 51
Select item for more details and to access through your institution.
Intracellular pH measured by <sup>31</sup> P-MR-spectroscopy might predict site of progression in recurrent glioblastoma under antiangiogenic therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2373, doi. 10.1007/s00432-021-03511-y
- By:
- Publication type:
- Article
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 8, p. 1581, doi. 10.1007/s00432-018-2671-z
- By:
- Publication type:
- Article
ERGO: A pilot study of ketogenic diet in recurrent glioblastoma.
- Published in:
- International Journal of Oncology, 2014, v. 44, n. 6, p. 1843, doi. 10.3892/ijo.2014.2382
- By:
- Publication type:
- Article
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 1, p. 39, doi. 10.15252/emmm.201505505
- By:
- Publication type:
- Article
Bevacizumab for Patients with Recurrent Multifocal Glioblastomas.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 11, p. 2469, doi. 10.3390/ijms18112469
- By:
- Publication type:
- Article
Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 4, p. 726, doi. 10.3390/ijms18040726
- By:
- Publication type:
- Article
Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.
- Published in:
- Neuroradiology, 2015, v. 57, n. 1, p. 11, doi. 10.1007/s00234-014-1445-9
- By:
- Publication type:
- Article
Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2031, doi. 10.3390/jcm8122031
- By:
- Publication type:
- Article
Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 8, p. 216, doi. 10.3390/jcm7080216
- By:
- Publication type:
- Article
Chemotherapy for adult patients with spinal cord gliomas.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 4, p. 475, doi. 10.1093/nop/npab017
- By:
- Publication type:
- Article
Hypoxia Enhances the Antiglioma Cytotoxicity of B10, a Glycosylated Derivative of Betulinic Acid.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094921
- By:
- Publication type:
- Article
Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0056439
- By:
- Publication type:
- Article
Comprehensive diagnostics in a case of hereditary diffuse leukodystrophy with spheroids.
- Published in:
- BMC Neurology, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12883-015-0368-3
- By:
- Publication type:
- Article
Comprehensive diagnostics in a case of hereditary diffuse leukodystrophy with spheroids.
- Published in:
- BMC Neurology, 2015, v. 15, n. 1, p. 103, doi. 10.1186/s12883-015-0368-3
- By:
- Publication type:
- Article
Comprehensive diagnostics in a case of hereditary diffuse leukodystrophy with spheroids.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Very late relapses in glioblastoma long-term survivors.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Quantitative T1 mapping indicates tumor infiltration beyond the enhancing part of glioblastomas.
- Published in:
- NMR in Biomedicine, 2020, v. 33, n. 3, p. N.PAG, doi. 10.1002/nbm.4242
- By:
- Publication type:
- Article
Fitting algorithms and baseline correction influence the results of non‐invasive in vivo quantitation of 2‐hydroxyglutarate with <sup>1</sup>H‐MRS.
- Published in:
- NMR in Biomedicine, 2019, v. 32, n. 1, p. N.PAG, doi. 10.1002/nbm.4027
- By:
- Publication type:
- Article
Improved visibility of brain tumors in synthetic MP-RAGE anatomies with pure T<sub>1</sub> weighting.
- Published in:
- NMR in Biomedicine, 2015, v. 28, n. 7, p. 818, doi. 10.1002/nbm.3324
- By:
- Publication type:
- Article
Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve IDH Wild-Type Glioma.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4060, doi. 10.3390/cancers13164060
- By:
- Publication type:
- Article
Non-Invasive Measurement of Drug and 2-HG Signals Using 19 F and 1 H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3175, doi. 10.3390/cancers12113175
- By:
- Publication type:
- Article
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma.
- Published in:
- Neuropathology & Applied Neurobiology, 2021, v. 47, n. 3, p. 379, doi. 10.1111/nan.12669
- By:
- Publication type:
- Article
RARE-19. CHEMOTHERAPY FOR SPINAL GLIOMAS IN ADULTS: A RETROSPECTIVE STUDY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi240, doi. 10.1093/neuonc/noy148.993
- By:
- Publication type:
- Article
QOLP-20. QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi218, doi. 10.1093/neuonc/noy148.906
- By:
- Publication type:
- Article
ACTR-64. OBJECTIVE RESPONSES TO CHEMOTHERAPY IN RECURRENT GLIOMA DO NOT PREDICT BETTER SURVIVAL: A PROSPECTIVE ANALYSIS FROM THE GERMAN GLIOMA NETWORK.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi26, doi. 10.1093/neuonc/noy148.094
- By:
- Publication type:
- Article
HOUT-09. USING THE ASCO AND ESMO FRAMEWORKS TO ASSESS THE CLINICAL VALUE OF TUMOR TREATING FIELDS FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi114, doi. 10.1093/neuonc/noy148.477
- By:
- Publication type:
- Article
Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 10, p. 1395, doi. 10.1093/neuonc/not105
- By:
- Publication type:
- Article
Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 12, p. 1349, doi. 10.1093/neuonc/nor132
- By:
- Publication type:
- Article
Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 9, p. 1020, doi. 10.1093/neuonc/nor099
- By:
- Publication type:
- Article
Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.
- Published in:
- Brain: A Journal of Neurology, 2005, v. 128, n. 9, p. 2200, doi. 10.1093/brain/awh563
- By:
- Publication type:
- Article
Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.
- Published in:
- Epilepsia (Series 4), 2016, v. 57, n. 12, p. 2056, doi. 10.1111/epi.13584
- By:
- Publication type:
- Article
P-Glycoprotein and Multidrug Resistance-associated Protein Mediate Specific Patterns of Multidrug Resistance in Malignant Glioma Cell Lines, but not in Primary Glioma Cells.
- Published in:
- Brain Pathology, 2003, v. 13, n. 4, p. 482, doi. 10.1111/j.1750-3639.2003.tb00479.x
- By:
- Publication type:
- Article
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
- Published in:
- Annals of Neurology, 2011, v. 70, n. 3, p. 445, doi. 10.1002/ana.22478
- By:
- Publication type:
- Article
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A <sup>1</sup>H-Magnetic Resonance Spectroscopy Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0168113
- By:
- Publication type:
- Article
Gliomatosis cerebri: no evidence for a separate brain tumor entity.
- Published in:
- Acta Neuropathologica, 2016, v. 131, n. 2, p. 309, doi. 10.1007/s00401-015-1495-z
- By:
- Publication type:
- Article
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.
- Published in:
- Acta Neuropathologica, 2015, v. 129, n. 1, p. 115, doi. 10.1007/s00401-014-1352-5
- By:
- Publication type:
- Article
Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.
- Published in:
- Acta Neurochirurgica, 2012, v. 154, n. 2, p. 229, doi. 10.1007/s00701-011-1144-9
- By:
- Publication type:
- Article
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 501, doi. 10.1007/s11060-019-03246-4
- By:
- Publication type:
- Article
Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 1, p. 93, doi. 10.1007/s11060-016-2144-7
- By:
- Publication type:
- Article
MR perfusion in and around the contrast-enhancement of primary CNS lymphomas.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 114, n. 1, p. 127, doi. 10.1007/s11060-013-1161-z
- By:
- Publication type:
- Article
Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 99, n. 1, p. 49, doi. 10.1007/s11060-009-0098-8
- By:
- Publication type:
- Article
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas.
- Published in:
- Oncology, 2021, v. 99, n. 4, p. 215, doi. 10.1159/000512562
- By:
- Publication type:
- Article
Confounding Factors in Diagnostics of MGMT Promoter Methylation Status in Glioblastomas in Stereotactic Biopsies.
- Published in:
- Stereotactic & Functional Neurosurgery, 2014, v. 92, n. 3, p. 129, doi. 10.1159/000360582
- By:
- Publication type:
- Article
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors.
- Published in:
- Oncology Letters, 2017, v. 14, n. 5, p. 5443, doi. 10.3892/ol.2017.6832
- By:
- Publication type:
- Article
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 1141, doi. 10.3892/ol.2017.6251
- By:
- Publication type:
- Article
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 123, doi. 10.1093/neuonc/noac099
- By:
- Publication type:
- Article
The High Energy Density Scientific Instrument at the European XFEL.
- Published in:
- Journal of Synchrotron Radiation, 2021, v. 28, n. 5, p. 1393, doi. 10.1107/S1600577521007335
- By:
- Publication type:
- Article